Sepsis severe et choc septique. [Severe sepsis and septic shock]

Details

Serval ID
serval:BIB_0415EFEB9B73
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Sepsis severe et choc septique. [Severe sepsis and septic shock]
Journal
Revue Médicale Suisse
Author(s)
Delaloye  J., Baumgartner  J. D., Calandra  T.
ISSN
1660-9379
Publication state
Published
Issued date
04/2006
Volume
2
Number
60
Pages
896-8, 900-2
Notes
English Abstract
Journal Article
Review --- Old month value: Apr 5
Abstract
Severe sepsis and septic shock are frequent pathologies accounting for approximately 11% of all admissions in intensive care units (ICU). In the United States, between 1979 and 2000 the incidence of sepsis increased by 8,7% annually and septic shock) remains the second most frequent cause of death in non-coronary ICU. Although our understanding of the host defense mechanisms against infections and of the pathogenesis of septic shock have progressed during the last decade, these progresses have not yet yielded the anticipated advantages. Recent new therapeutic approaches, especially early-goal directed therapy, activated protein C (drotrecogin alpha activated), moderate doses of corticosteroids and intensive insulin therapy have given encouraging results.
Keywords
Adrenal Cortex Hormones/therapeutic use Anti-Inflammatory Agents, Non-Steroidal/therapeutic use Humans Hypoglycemic Agents/therapeutic use Incidence Insulin/therapeutic use Intensive Care Units Prognosis Protein C/therapeutic use Recombinant Proteins/therapeutic use Sepsis/*complications/*therapy Shock, Septic/*etiology/*therapy United States/epidemiology
Pubmed
Create date
19/01/2008 18:12
Last modification date
20/08/2019 12:25
Usage data